Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportClinical Science

Risk stratification and therapy response values of 11C-PIB positron emission tomography for amyloid light-chain amyloidosis

Xuezhu Wang, Bowei Liu, Chao Ren, Zhenghai Huang, Haiyan Ding, Hui Zhang, Yajuan Gao, Xiao Li, Yining Wang, Zhuang Tian, Jian Li, Xiang Li and Li Huo
Journal of Nuclear Medicine June 2022, 63 (supplement 2) 2294;
Xuezhu Wang
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bowei Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chao Ren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenghai Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haiyan Ding
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Zhang
2Tsinghua University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yajuan Gao
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Li
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yining Wang
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhuang Tian
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Li
1Peking Union Medical College Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Li
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Huo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

2294

Introduction: 11C-PIB PET/CT has shown promise as a specific and non-invasive method for the diagnosis of cardiac amyloidosis (CA). The clinical risk stratification of patients with amyloid light-chain CA (AL-CA) still remained unclear. This prospective study evaluated 11C-PIB PET/CT of AL-CA in correlation with clinical staging and explored the potentials in therapy response.

Methods: This prospective study recruited 51 patients (age, 59.8±7.7 years; M/F, 34/17) with known AL-CA and 14 control patients (age, 58.9±8.2 years; M/F, 9/5; including 8 healthy controls and 6 non-amyloid hypertrophic). Subjects underwent echocardiography,a 11C-PIB-PET/CT 30min dynamic scan (SinoUnion PoleStar m660, China) after radiotracer injection with a dose of 415.3±116.0 MBq. Two simple semiquantitative approaches, standardized uptake value ratio (SUVR) and retention index (RI) were established for 11C-PIB analysis. The retention index (RI) derived from the time activity curve (TAC) was defined as the mean standardized uptake value (SUVmean) of the myocardial VOI from 10 to 20 min divided by the integral of the mean SUV of the left atrium (LA) blood VOI from 0 to 15 min. The standardized uptake value ratio (SUVR) was also defined as the SUVmean of the myocardial divided by the SUVmean of the LA. Additionally, the correlation between dynamic PET/CT parameters and clinical, echocardiography parameters were also assessed.

Results: Patients with AL-CA displayed an elevated cardiac uptake in comparison to controls presenting SUVR: 5.29±3.66) vs. controls (1.46±0.36, P=0.0002), as well as RI (0.159±0.11 vs. 0.038±0.01, P=0.0001). For identifying AL-CA, a cut-off value of 1.92 for SUVR showed a sensitivity of 90.2% and a specificity of 92.9% (AUC: 97.3% [95% CI]: 94% to 100%]) and a cut-off value of 0.053 for RI showed 100% sensitivity and specificity (AUC: 100%, 95%CI: 100%-100%). Association of dynamic PET/CT parameters and clinical features are shown in Table S1. Notably, Both SUVR and RI were significantly associated with NT-proBNP (P=0.019, P=0.006). SUVR was associated with left atrial diastolic diameter (LAD) (P=0.013). Six patients underwent follow-up 11C-PIB PET/CT after 9 cycles of chemotherapy. According to the consensus response criteria, 4 patients had a complete response and 2 patients had a very good partial response. Most patients showed a medium or marked reduction of cardiac uptake in 11C-PIB dynamic PET/CT, especially for myocardial RI and SUVmean (Figure S1). Patient case demonstrated lower myocardial uptake of posttreatment comparing with baseline scan, which can be observed by 11C-PIB PET/CT images as well as the corresponding TACs in Figure 1.

Conclusions: 11C-PIB PET was highly accurate in detecting AL-CA. 11C-PIB dynamic parameters were associated with several clinical parameters, which may potentially reflect disease burden and risk stratification. In addition, its value in the therapy response is promising.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
June 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk stratification and therapy response values of 11C-PIB positron emission tomography for amyloid light-chain amyloidosis
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Risk stratification and therapy response values of 11C-PIB positron emission tomography for amyloid light-chain amyloidosis
Xuezhu Wang, Bowei Liu, Chao Ren, Zhenghai Huang, Haiyan Ding, Hui Zhang, Yajuan Gao, Xiao Li, Yining Wang, Zhuang Tian, Jian Li, Xiang Li, Li Huo
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2294;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Risk stratification and therapy response values of 11C-PIB positron emission tomography for amyloid light-chain amyloidosis
Xuezhu Wang, Bowei Liu, Chao Ren, Zhenghai Huang, Haiyan Ding, Hui Zhang, Yajuan Gao, Xiao Li, Yining Wang, Zhuang Tian, Jian Li, Xiang Li, Li Huo
Journal of Nuclear Medicine Jun 2022, 63 (supplement 2) 2294;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Role of FDG PET scan in evaluating the extent of viability using quantitative method in addition to routine visual method, and its impact on management and clinical outcome.
  • xSPECT-based myocardial perfusion scintigraphy: feasibility of myocardial uptake quantitation in patients with suspected coronary artery disease – a pilot study
  • Non-Invasive Measurement of Increased Vessel Wall Inflammation by [18F]FDG PET/CT in Patients with Multiple Myeloma upon Allogeneic Hematopoietic Cell Transplantation
Show more Clinical Science

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire